SCHEMBL3668017

SCHEMBL3668017

Cc1c([N+](=O)[O-])cc2c(c1C)[N]C(=O)C(=O)N2

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CCR6 P51684 1/20 0.36
CYP1A2 P05177 2/20 0.36
KDM4E B2RXH2 1/20 0.35
TDP1 Q9NUW8 2/20 0.33
POLB P06746 1/20 0.33
CAPN9 O14815 1/20 0.33
CASP3 P42574 1/20 0.33
HSD17B10 Q99714 1/20 0.33
CHEK1 O14757 2/20 0.32
GRIN2D O15399 2/20 0.32
GRIN3B O60391 2/20 0.32
GRIN1 Q05586 2/20 0.32
GRIN2A Q12879 2/20 0.32
GRIN2B Q13224 2/20 0.32
GRIN2C Q14957 2/20 0.32
GRIN3A Q8TCU5 2/20 0.32
TSHR P16473 4/20 0.32
MAPT P10636 3/20 0.32
CYP3A4 P08684 2/20 0.32
LMNA P02545 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3674251 0.88 TSHR (0.38) CCR6CYP1A2KDM4ETDP1POLB
SCHEMBL3668151 0.82 GPR35 (0.42) CYP1A2KDM4ETDP1POLBCAPN9
SCHEMBL8551898 0.82 MAPT (0.31) CCR6CYP1A2MAPT
SCHEMBL2903425 0.82 LMNA (0.32) CCR6CYP1A2MAPTLMNASMN1; SMN2
SCHEMBL8113307 0.78 GRIN2D (0.42) CYP1A2TDP1POLBCAPN9CASP3
SCHEMBL8123057 0.77 ALDH1A1 (0.40) CYP1A2KDM4ETDP1POLBCAPN9
SCHEMBL8123110 0.77 GRIN2D (0.33) CYP1A2CAPN9CASP3GRIN2DGRIN3B
SCHEMBL8128520 0.77 CAPN9 (0.31) CYP1A2CAPN9CASP3GRIN2DGRIN3B
SCHEMBL8122907 0.77 TSHR (0.35) CYP1A2TDP1CAPN9CASP3GRIN2D
SCHEMBL8127087 0.77 CAPN9 (0.31) CYP1A2CAPN9CASP3GRIN2DGRIN3B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2150248-A2 GLUTAMATE RECEPTOR ANTAGONISTS AND METHODS OF USE The Johns Hopkins University (US) 2010-02-10 EP disclosed
WO-2008088820-A2 GLUTAMATE RECEPTOR ANTAGONISTS AND METHODS OF USE THE JOHNS HOPKINS UNIVERSITY (US) 2008-07-24 WO disclosed
WO-1998023599-A1 UREA AND THIOUREA DERIVATIVES OF SUBSTITUTED QUINOXALINE 2,3-DIONES AS GLUTAMATE RECEPTOR ANTAGONISTS WARNER-LAMBERT COMPANY (US) 1998-06-04 WO disclosed